According to Xilio Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.07. In 2022 the company made an earnings per share (EPS) of -$3.22 a decrease over its 2021 EPS that were of -$3.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.07 | -4.66% |
2022 | -$3.22 | 4.42% |
2021 | -$3.08 |